⚕ GalenOps CRO console
← 710 (USA)

710-1060

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 710 (USA) (Dr. Silva) · consented 2013-01-01
Adverse events
8
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild APPLICATION SITE INDURATION — outcome: RECOVERED/RESOLVED; onset 2013-01-21 (study day 21.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-01-23 (study day 23.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-01-31 (study day 31.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild FALL — outcome: RECOVERED/RESOLVED; onset 2013-02-08 (study day 39.0); relationship: NONE

mild assessed 2026-08-18

Mild FALL — outcome: RECOVERED/RESOLVED; onset 2013-02-09 (study day 40.0); relationship: NONE

mild assessed 2026-08-18

Mild INSOMNIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-04 (study day 4.0); relationship: NONE

mild assessed 2026-08-18

Mild INSOMNIA — outcome: RECOVERED/RESOLVED; onset 2013-01-04 (study day 4.0); relationship: NONE

mild assessed 2026-08-18

Mild NASAL CONGESTION — outcome: RECOVERED/RESOLVED; onset 2013-01-02 (study day 2.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.